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Abstract

Methods

Results

In November 2013 new statin guidelines were released.
Generally, physicians are slow to adopt new guidelines and
adherence to new guidelines often remains low even years
after they have been issued. In this study, multiple
interventions, including patient handouts, email reminders,
and education sessions were implemented to increase
adherence with new statin prescribing guidelines in a large
urban practice. The numbers of prescriptions were analyzed
for 6 weeks prior to and 6 weeks after the interventions. Statin
prescribing in diabetic patients not already on a statin preintervention was 11.7% and post-intervention was 13.0% (pvalue 0.5936). There was a small increase in prescribing postintervention but no statistical significance. The study was
limited by multiple factors leaving room for further research in
this area.

The study consisted of three phases: 1. Pre-intervention data
analysis of percentage of active Jefferson Family Medicine patients
ages 40-75 years with type II diabetes who were on statin therapy
versus those who were not; 2. Implementation of four different
educational interventions; and 3. Post-implementation data analysis
of the same population.

In the pre-intervention group, there were 1120 diabetic
encounters. In 780 of these, diabetics were already on a statin
(69.9%) and in 428 (30.1%), diabetics were not on a statin. Of
the 428 opportunities to prescribe a statin, statins were
prescribed 50 times (11.7%). In the post-intervention group,
there were 1166 diabetic encounters. In 844 of these,
diabetics were already on a statin (72.4%) and 384 (27.6%)
were not. Of the 384 statin opportunities, statins were
prescribed 50 times (13.0%). The difference in statin
prescriptions for diabetic patients not already on statins preand post-intervention had a P value of 0.5936.

Background
In November 2013, the AHA and ACC released new statin guidelines
targeting four groups who would benefit from moderate to highintensity statin therapy to reduce ASCVD risk. One of these groups
was diabetic patients between the ages of 40 and 75.
Generally, physicians are slow to adopt new guidelines and
adherence to new guidelines often remains low even years after
they have been issued. This leads directly to suboptimal patient
outcomes and resource wasting.

Four interventions were implemented in March 2015 (Figure 1).
1. Distribution of a statin education handout (Figure 2) to patients
to encourage them to ask their providers about statins.
2. Posting of a flyer (Figure 2) in each exam room to prompt
providers to address the need for statins.
3. Leading a teaching session for providers describing the new
statin guidelines.
4. Sending a practice wide email describing the new statin
guidelines
A data query was done which compiled visit information from
patients between the ages of 40-75 years old with Type II Diabetes
Mellitus ICD-9 codes who had never been prescribed a statin.
Patients with statin allergies were excluded. The data query looked
at visits 6 weeks pre-intervention and 6 weeks post-intervention.
Data was analyzed using a two-tailed Fischer exact test.

Research in this area has garnered considerable interest in recent
years. Numerous studies have looked at various methods to improve
guideline adherence and have compared their effectiveness. None
has emerged as clearly superior and there is still work to be done to
determine which intervention(s) is best.

Discussion
The aim of this study was to increase physician adherence to
the new statin guidelines using a multi-faceted intervention
approach. While the results showed a slight increase in
percentage of statin prescriptions post-intervention (11.7% 
13.0%), the difference was not statistically significant
(p=0.5936).

At Jefferson Family Medicine, there are many diabetic patients who
are not yet on a statin and the reasons underlying the less-thanperfect adherence with the new guidelines are complex. With our
study, we aimed to improve our compliance with the statin
guidelines by intervening in multiple ways to increase the number of
diabetic patients on statins.
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Figure 1

Figure 2

Physicians are notoriously slow at adapting to new guidelines.
However, there are several factors that may have affected our
results. The study was done at a large academic center and
prior to the study period, the entire department had grand
rounds on the new statin guidelines and the residents had
another lecture as well. Additionally, the department has a
quality care group that helps discuss and increase adherence to
guidelines at all times. In addition, the reasons for nonprescribing were not evaluated and may have included patient
preference despite physician recommendation.
In addition, the new guidelines recommend certain doses of
statins for these diabetic patients and we were not able to
query if doses were changed per guideline recommendations.
In the future, it is reasonable to look further into statin
prescription habits as well as comparing different interventions
to see which is the best at changing physician habits.

